These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of HLA-DR antigen expression and of the allogeneic mixed leukocyte reaction by photochemical treatment. Gruner S; Volk HD; Noack F; Meffert H; von Baehr R Tissue Antigens; 1986 Mar; 27(3):147-54. PubMed ID: 2940731 [TBL] [Abstract][Full Text] [Related]
3. HLA-D and -DR antigens on human amniotic fluid cells. I. Lack of expression of HLA-D. Valentine-Thon E; Kreeb G; Grosse-Wilde H; Passarge E Tissue Antigens; 1983 Feb; 21(2):138-47. PubMed ID: 6221440 [TBL] [Abstract][Full Text] [Related]
4. Functional defect of heat-inactivated human lymphocytes in mixed-lymphocyte culture. Boyer CM; Kostyu DD; Brissette CS; Amos DB Cell Immunol; 1986 Sep; 101(2):440-53. PubMed ID: 2944610 [TBL] [Abstract][Full Text] [Related]
5. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868 [TBL] [Abstract][Full Text] [Related]
6. Variable MLC stimulatory capacity of neoplastic B and non-B/non-T lymphocytes expressing HLA-DR antigens. Bom-van Noorloos AA; Schreuder I; de Groot-Swings G; Ubels-Postma J; von dem Borne AE; Melief CJ Tissue Antigens; 1982 Nov; 20(5):352-63. PubMed ID: 6218653 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. Masuyama J; Minato N; Kano S J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562 [TBL] [Abstract][Full Text] [Related]
8. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
9. The active rosette mixed-lymphocyte reaction: an early marker of lymphocyte activation linked to HLA-D-DR differences. Wybran J; Dupont E Clin Immunol Immunopathol; 1983 Apr; 27(1):51-5. PubMed ID: 6223752 [TBL] [Abstract][Full Text] [Related]
10. Histocompatibility antigens, mixed lymphocyte reactivity and severe preeclampsia in Israel. Persitz E; Oksenberg J; Amar A; Margalioth EJ; Cohen O; Brautbar C Gynecol Obstet Invest; 1983; 16(5):283-91. PubMed ID: 6227533 [TBL] [Abstract][Full Text] [Related]
11. Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells. Shaut DM; Ireland J; Scornik JC; Peck AB Hum Immunol; 1983 Jun; 7(2):105-15. PubMed ID: 6190790 [TBL] [Abstract][Full Text] [Related]
12. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line. Yamamoto M; Yano A J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233 [TBL] [Abstract][Full Text] [Related]
13. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses. Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414 [TBL] [Abstract][Full Text] [Related]
14. The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells. Taramelli D; Fossati G; Balsari A; Marolda R; Parmiani G Int J Cancer; 1984 Dec; 34(6):797-806. PubMed ID: 6334655 [TBL] [Abstract][Full Text] [Related]
15. Plaque-forming cells in man. III. Generation of plaque-forming cells in allogeneic in vitro cultures of HLA-D/DR-incompatible B and T lymphocytes. Tauris P; Johnsen HE; Christiansen SE; Kissmeyer-Nielsen F Scand J Immunol; 1984 May; 19(5):419-24. PubMed ID: 6233695 [TBL] [Abstract][Full Text] [Related]
16. An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses. Taylor GM; Fergusson W; Dyer PA; Harris R; Morrell G Cancer Immunol Immunother; 1983; 16(2):117-22. PubMed ID: 6229327 [TBL] [Abstract][Full Text] [Related]
17. Human suppressor cell induction in vitro: preferential activation by class I MHC antigen. Goeken NE J Immunol; 1984 May; 132(5):2291-9. PubMed ID: 6232315 [TBL] [Abstract][Full Text] [Related]
18. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. I. Variations in generation of anti-class-II CTL in primary mixed lymphocyte cultures. Breuning MH; Breur BS; Engelsma MY; Iványi P Tissue Antigens; 1984 Aug; 24(2):81-9. PubMed ID: 6238446 [TBL] [Abstract][Full Text] [Related]
19. Loss of HLA-DR expression by human epidermal cells after growth in culture. Hefton JM; Amberson JB; Biozes DG; Weksler ME J Invest Dermatol; 1984 Jul; 83(1):48-50. PubMed ID: 6376639 [TBL] [Abstract][Full Text] [Related]
20. Serological distinction between DR antigens and lymphocyte activating determinants. van Heyningen V; Cohen BB; Deane DL; Gray C; Steel CM Tissue Antigens; 1981 Feb; 17(2):149-61. PubMed ID: 6165093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]